Epidemiology and pathogenesis of esophageal cancer: Management and its controversial results (Review)

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 449-454

  Stathopoulos, G P ^a   Tsiaras, N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Controversies; Esophageal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; REVIEW; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; RADIOTHERAPY DOSAGE;

EID: 0038487102     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.449     Document Type: Review

References (47)

1. Blot WJ and McLaughlin JK: The changing epidemiology of esophageal cancer. Semin Oncol 5 (Suppl. 15): 2-8, 1999. (Pubitemid 29529530)
2. Various monographs on the evaluation of the carcinogenic risk of chemicals to humans - some metals and metallic compounds. International Agency of Research on Cancer, Vol. 23, Lyon, 1980.
3. Blot WJ and Fraumeni JF: Geographic epidemiology of cancer in the United States. In: Cancer Epidemiology and Precaution. Schotterfed D and Fraumeni J (eds). W.B. Saunders Co., Philadelphia, pp 179, 1982.
4. Lord RV, Law MG, Ward RL, et al: Rising incidence of esophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol 13: 356-362, 1998. (Pubitemid 28215942)
5. Gamlier Z: Incidence, epidemiology and etiology of esophageal cancer. Chest Surg Clin N Am 10: 3, 2000.
6. Blot WJ, Devessa SS and Kneller RW: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287-1289, 1991.
7. Devessa SS, Blot WJ and Fraumeni JF: Changing patters in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2059, 1998.
8. Heitmiller FM and Sharma RR: Comparison of incidence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma. J Thorac Cardiovasc Surg 112: 130-136, 1996.
9. Powell J and McKousey CC: The rising trend in esophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1: 265-269, 1992.
10. Pera M, Cameron AS, Trastec VF, Carpenter HA and Zinsmeister AR: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104: 510-513, 1993. (Pubitemid 23033424)
11. Sporn MB and Newton DL: Chemoprevention of cancer with retinoids. FASEB J 38: 2528, 1979.
12. Malboudi EO and Aramesh B: Epidemiology of esophageal cancer in Iran, with special reference to nutritional and cultural aspect. Prev Med 9: 613, 1980.
13. Heimberger DC: Localized deficiencies of toxic acid in aerodigestive tissues. Am NY Acad Sci 669: 87-95, 1992.
14. Saskiewicz K, Marasas F, Roussouw JE, et al: Selenium and other mineral elements in population at risk for esophageal cancer. Cancer 62: 2635-2639, 1988.
15. Li SY, Taylor PR, Li B, et al: Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation cancer incidence and disease specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85: 1492-1498, 1993.
16. Blot WJ, Li SY, Taylor PR, et al: Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation cancer incidence and disease specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85: 1483-1492, 1993. (Pubitemid 23269183)
17. Yang CS and Waug ZY: Tea and cancer. J Natl Cancer Inst 85: 1038-1049, 1993. (Pubitemid 23199184)
18. Gao YT, McLaughlin JF, Blot WJ, et al: Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 86: 855-858, 1994. (Pubitemid 24164664)
19. Heitmiller RF: Epidemiology, diagnosis and staging of esophageal cancer. Cancer Treat Res 105: 375-386, 2001.
20. Sammon AM and Anderson D: Diet reflux and the development of squamous cell carcinoma of the esophagus in Africa. Br J Surg 85: 891-896, 1998. (Pubitemid 28341554)
21. Maillefer RG and Graydams MP: To B or not to B: is tylosis B truly benign. Am J Gastroenterol 94: 829-894, 1994.
22. Moutesano R, Holistein M and Bainaut P: Genetic alterations in esophageal cancers and their relevance to etiology and pathogenesis: a review. Int J Cancer 69: 225-235, 1996.
23. Stahl M, Wilke H, Eigler FW and Budach V: Ösophaguskarzinom. Kompedium Internisticsche Onkologie. Stantards in Diagnostik and Trerapie. Teil 2. Springer, Berlin, Heidelberg, New York, pp873-894, 1999.
24. Ferguson MK: Neoplasms of esophagus. In: Cancer Medicine. 5th edition. BC Decker Inc., Lewiston, New York, pp1340-1354, 2000.
25. Wallace MB: Optimal staging strategies for carcinoma of the esophagus: does it make a difference? ASCO Educational Book, pp221-226, 2002.
26. AJCC Cancer Staging Manual. Lippincott, Raven, Philadelphia, PA, 1997.
27. Rice TW and Adelstein DJ: Precise clinical staging allows treatment modification of patients with esophageal carcinoma. Oncology 11: 58-62, 1997. (Pubitemid 27425682)
28. Rice TW, Blackstone EH, Adelstin DJ, et al: Esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg 121: 454-464, 2001. (Pubitemid 32230213)
29. Mayer RJ: Esophageal cancer: primary management of local-regional disease. ASCO Educational Book, pp207-211, 2002.
30. Earlam R and Cunha-Melo JR: Esophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg 67: 381-390, 1980. (Pubitemid 10059625)
31. Roth JA and Putnam JB Jr: Surgery for cancer of the esophagus. Semin Oncol 21: 453-461, 1994. (Pubitemid 24256836)
32. Wobst A, Audisio RA, Colleoni M, et al: Oesophageal cancer treatment: studies, strategies, facts. Ann Oncol 9: 931-942, 1998.
33. Earlam R and Cunha-Melo JR: Esophageal squamous cell carcinoma. II. A critical review of radiotherapy. Br J Surg 67: 457-461, 1980. (Pubitemid 10080131)
34. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB and Shields TW: Cisplatin and 5-Fluorouracil in the primary management of squamous esophageal cancer. Cancer 60: 2156-2160, 1987. (Pubitemid 17153474)
35. Forastiere AA, Orringer MB, Perez-Tamayo C, et al: Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 8: 119-127, 1990. (Pubitemid 20032454)
36. Forastiere AA, Orringer MB, Perez-Tamayo C, Mrba SG and Zahura KM: Preoperative chemoradiation followed by transhiatal esophagectomy of carcinoma of the esophagus: final report. J Clin Oncol 11: 1118-1123, 1993. (Pubitemid 23163353)
37. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedauin D, et al: A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779-1784, 1994. (Pubitemid 24101950)
38. Orringer M, Forastiere A, Perez-Tamayo C, Mrba S, Takasugi B, et al: Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 49: 348-355, 1990. (Pubitemid 20097025)
39. Gignoux M, Bosset JF, Apoil B, Gillet M, Triboulet JP, Ollivier JM, el al: Radiocliimiothérapie adjuvante dans les cancers opérables de l'oesophage thoracique résultat préliminaire d'une étude multicentrique, étude portant sue 119 cas. Ann Chi r43: 269-274, 1989. (Pubitemid 19118743)
40. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevieius V, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
41. Gill P, Denhaum J, Jamieson G, Dewitt P, Yeah E and Olweny C: Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment of followed by surgery. J Clin Oncol 10: 1037-1043, 1992.
42. Bates BA, Detterbeck FC, Bernard SA, Quqish BF and Tapper JE: Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma J Clin Oncol 14: 156-163, 1996. (Pubitemid 26020008)
43. Walsh TN, Nooman N, Hollywood D, Kelly A, Keeling N and Henessy TPJ: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335: 462-467, 1996. (Pubitemid 26269945)
44. Bosset JF, Gignoux M, Triboulet JP, Tivet E, Mantion G, Elias D, et al: Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 337: 161-167, 1997. (Pubitemid 27306287)
45. Kelsen DP, Giusberg R, Pajak TF, Sheakan GD, Gunderson L, Mortimer J, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979-1984, 1998. (Pubitemid 29024130)
46. Ancoua E, Ruel A, Santo S, Merigliano S, Chiaron-Sibuni V, Koussis H, et al: Only pathological complete response to neoadjuvant chemotherapy improves significantly the long-term survival of patients with resectable esophageal squamous cell carcinoma. Cancer 91: 2165-2174, 2001.
47. Ilson DH: Esophageal cancer: new development in systemic therapy. ASCO Educational Book, pp212-220, 2002.